BioNeutral Confirms Broad Spectrum Efficacy with Its Ygiene(TM) Antimicrobial

Ygiene(TM) Antimicrobial Has Been Found to Eradicate Clostridium Difficile (C.
diff.) Spores in Seconds

NEWARK, N.J., July 22 /PRNewswire/ -- BioNeutral announces successful
independent laboratory test results which showed that Ygiene(TM) completely
eliminates C. diff. spores in seconds. C. diff. represents a very serious
health threat to people recovering from surgery or other serious illnesses in
hospitals, convalescent homes, for the elderly and for health care providers.
Ygiene's(TM) ability to eliminate C. diff. spores in seconds means that health
care facilities can quickly be disinfected and made safe, thereby saving
thousands of lives a year.
Dr. Philip Tierno, Director of Clinical Microbiology and Diagnostic
Immunology at Langone Medical Center, New York University, has previously
tested Ygiene(TM) against a broad spectrum of microorganisms and is very
familiar with its attributes. Dr. Tierno describes Ygiene(TM) 301 as follows:
"There is nothing better. (Virtually nothing compares with it)
There is nothing that works faster. (Kills in seconds)
There is nothing that has a more complete kill. (Kills 100% of organisms)
There is nothing wider in spectrum. (Kills any and all microbes)
There is nothing that leaves the environment more green. (It eventually
breaks down into innocuous substances.)"
Dr. Andy Kielbania, Chief Scientist at BioNeutral, stated that "We are
extremely pleased with these independent laboratory results which show that
Ygiene(TM) can significantly reduce the health risks associated with harmful
microorganisms for all people in the health care arena. These results along
with previous test results affirm the potent broad spectrum efficacy of our
Ygiene(TM) antimicrobial."
About BioNeutral Laboratories Corporation
BioNeutral was organized in 2003 to commercialize a novel combinational
chemistry-based technology that can neutralize harmful environmental
contaminants, toxins and dangerous micro-organisms including bacteria, viruses
and spores. The formulations are "Green" and include natural and common
ingredients which are found in baby products and the foods we eat. These
widely used compounds are combined in unique ways to create enhanced results.
BioNeutral's proprietary platform technology has been proven effective in
surface, water and airborne applications. The products include BioNeutralizers
and ChemoNeutralizers. BioNeutralizers disinfect, decontaminate and sterilize.
BioNeutral believes it has the broadest-based, fastest acting, most effective
and safest antimicrobial known. This class of products has important
applications for consumers, healthcare and the military. ChemoNeutralizers
irreversibly bind chemical contaminant and toxin molecules and render them
harmless. Product applications include industrial pollution and protection
against chemical weapons of mass destruction.
About Dr. Philip Tierno
Dr. Tierno is a consultant to BioNeutral. He is the Director of Clinical
Microbiology and Diagnostic Immunology at Langone Medical Center, New York
University. He is also an Associate Professor at the New York University
School of Medicine, NYU College of Dentistry and SUNY School of Optometry in
New York City. Dr. Tierno is a member of the NYC Mayor's MRC (Medical Reserve
Corps) and a former member of New York City's task force on bioterrorism. Dr.
Tierno's work in the field of microbiology has resulted in numerous articles
and texts that have been published in medical and scientific journals. He is
co-editor and author of several books on microbes and biological protection.
Contact:

Info@bioneutralgroup.com

Dr. Andy Kielbania
Chief Scientist
andy@bioneutralgroup.com

Dr. Philip Tierno
Consultant
philip.tierno@nyumc.org

This release was issued through eReleases(TM). For more information,
visit http://www.ereleases.com.
SOURCE BioNeutral Laboratories Corporation

Dr. Andy Kielbania, Chief Scientist of BioNeutral Laboratories Corporation,
andy@bioneutralgroup.com; or Dr. Philip Tierno, Consultant for BioNeutral
Laboratories Corporation, philip.tierno@nyumc.org